Intractable vascular anomalies
Conditions
Interventions
None listed
Sponsors
Gifu University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Intractable vascular anomalies who visited to the hospital from 2007 to 2022
Exclusion criteria
Exclusion criteria: Patients who have had an offer of non-participation in research Patients who have not left enough clinical record information
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of intractable vasacular anomalies in Japan | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The differences of clinical symptoms and prognosis of each vascular anomalies 2. The comparison of clinical parameters (respiratory function, pleural effusion, coagulation data, pain scales, bleeding scales, severity) 3. The efficacy of each treatments 4. Clinical validity of severity scores | — |
Countries
Japan
Contacts
Public ContactMichio Ozeki
Gifu University Hospital The department of Pediatrics
Outcome results
None listed